Cancer-specific SPANX-N markers

Details for Australian Patent Application No. 2005316532 (hide)

Owner Government of the United States of America as represented by the Secretary of the Department of Health and Human Services

Inventors Kouprina, Natalay; Goldsmith, Paul; Barrett, J. Carl; Larionov, Vladimir

Agent Griffith Hack

Pub. Number AU-A-2005316532

PCT Pub. Number WO2006/065938

Priority 60/636,811 15.12.04 US

Filing date 15 December 2005

Wipo publication date 22 June 2006

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

12 July 2007 PCT application entered the National Phase

  PCT publication WO2006/065938 Priority application(s): WO2006/065938

15 May 2008 Alteration of Name

  The name of the applicant has been altered to Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services, National Institutes of Health 2006

14 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005316534-Identification and use of prognostic and predictive markers in cancer treatment

2005316528-Stack-up configuration for a wireless communication device